Valuation: Sandu Pharmaceuticals Limited

Market Cap 295M 3.04M 2.68M 2.49M 2.29M 4.29M 4.37M 29.75M 11.6M 144M 11.43M 11.18M 499M P/E 2024
38x
P/E 2025 30.6x
Enterprise Value 273M 2.82M 2.48M 2.3M 2.12M 3.97M 4.05M 27.55M 10.75M 133M 10.59M 10.36M 462M EV / Sales 2024
0.81x
EV / Sales 2025 0.67x
Free-Float
-
Yield 2024
1.39%
Yield 2025 1.63%
06-19 Sandu Pharmaceuticals Limited Announces Demise of Umesh Sandu, Member of Audit Committee and Stakeholders Relationship Committee CI
06-19 Sandu Pharmaceuticals Limited Announces the Demise of Umesh Sandu, Managing Director CI
05-05 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
05-05 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended 31 March 2026 CI
02-06 Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-12 Sandu Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-30 Sandu Pharmaceuticals Limited Approves the Continuation of Shri Vijay Kajarakar as Chief Financial Officer CI
25-08-13 Sandu Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-28 Sandu Pharmaceuticals Posts INR3.3 Million Profit in Fiscal Q4 MT
25-05-28 Sandu Pharmaceuticals Limited Recommends Final Dividend for the Financial Year Ended March 31, 2025, on or Before October 25, 2025 CI
25-05-28 Sandu Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-02-13 Sandu Pharmaceuticals Limited Announces Resignation of Shubhada Sandu as Non Executive Non Independent Director CI
25-02-13 Sandu Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
1 day-0.07%
1 month-2.71%
3 months-6.71%
6 months+24.20%
Current year+9.54%
1 week 37.3
Extreme 37.3
41.5
1 month 37.3
Extreme 37.3
42
Current year 30
Extreme 30
50
1 year 30
Extreme 30
58.28
3 years 30
Extreme 30
85
5 years 30
Extreme 30
86
10 years 10.45
Extreme 10.45
86
Manager TitleAgeSince
Chief Executive Officer 58 2026-07-10
Director of Finance/CFO - 2024-03-29
Compliance Officer - -
Director TitleAgeSince
Director/Board Member 62 2011-05-31
Chairman 58 2024-03-29
Director/Board Member 68 2023-08-13
Change 5-day change 1-year change 3-year change Capi.($)
-0.07%0.00%-16.97%-22.63% 4.11M
-0.10%+1.77%-8.51%-3.35% 13.64B
-0.65%+2.26%-28.71%-50.29% 5.26B
-0.31%+2.46%+0.25%-1.00% 4.85B
-1.74%-2.87%+6.61%-30.00% 4.25B
-0.45%-3.10%+3.70%-7.77% 3.75B
-1.64%+4.45%-3.84%-1.75% 3.74B
-0.31%+4.32%-2.15%+12.88% 3.53B
-1.25%-1.56%-11.88%-21.43% 2.49B
+0.85%-1.35%-2.67%+49.54% 1.86B
Average -0.57%+1.28%-6.42%-7.58% 4.34B
Weighted average by Cap. -0.56%+1.18%-6.47%-9.09%

Financials

2024 2025
Net sales 673M 6.95M 6.11M 5.68M 5.22M 9.79M 9.97M 67.88M 26.48M 328M 26.08M 25.52M 1.14B 672M 6.94M 6.1M 5.67M 5.21M 9.78M 9.95M 67.79M 26.44M 328M 26.05M 25.48M 1.14B
Net income 14.61M 151K 133K 123K 113K 213K 216K 1.47M 575K 7.13M 566K 554K 24.73M 15.52M 160K 141K 131K 120K 226K 230K 1.57M 611K 7.57M 602K 589K 26.26M
Net Debt -11.43M -118K -104K -96.43K -88.69K -166K -169K -1.15M -450K -5.58M -443K -434K -19.34M -21.76M -225K -198K -184K -169K -317K -322K -2.19M -856K -10.61M -843K -825K -36.81M
Logo Sandu Pharmaceuticals Limited
Sandu Pharmaceuticals Limited is an India-based company, which is mainly engaged in the business of manufacturing and trading of ayurvedic medicines under the brand name, SANDU. The Company's product category includes digestive health, immunity, muscle and bone health, respiratory health, wellness, and others. Its digestive health products focus on constipation, hyperacidity, indigestion and flatulence, and loose motions, among others. Its wellness products cover female wellness, male wellness and mother and child. Its respiratory health products focus on respiratory health, asthma, and cold and cough. Its ayurveda category includes herbs, panchakarma, dincharya, rutucharya, ahar vihar, arogyadarshika, prakruti and yoga. The Company also offers products, such as an immunity kit and a power herbs range. Its products are manufactured using in-house know-how supplied by Sandu Brothers Private Limited. The Company's products are sold through e-commerce marketplaces.
Employees
303
Date Price Change Volume
26-07-23 41.00 -0.07% 317
26-07-22 ₹41.03 +3.74% 6,564
26-07-21 ₹39.55 +3.64% 2,257
26-07-17 ₹38.16 -3.69% 696
26-07-16 ₹39.62 -3.37% 214
  1. Stock Market
  2. Stocks
  3. SANDUPHQ6 Stock